Prophylactic Human Vaccines gives protection against human papillomavirus (HPV) infection. There are nearly 200 types of HPV among which 40 transmitted by sexual contact and some of them also known to produce malignancies such as, cervical, penile, vulvar, vaginal etc. The prophylactic human vaccines have weakened microbes which are further stimulated by body to produce antibodies for encountering HPV.
MARKET DYNAMICS
The key market drivers for Prophylactic Human Vaccines Market Includes, rising prevalence of cervical cancers as well as increased in HPV infection. Moreover, government initiatives for boosting R&D activities for vaccine production is also expected to fuel market growth during forecast period. Whereas, high cost of overall research and high cost of vaccine is expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Prophylactic Human Vaccines Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Prophylactic Human Vaccines market with detailed market segmentation by vaccine technology. The Prophylactic Human Vaccines Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Prophylactic Human Vaccines Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Prophylactic Human Vaccines Market is segmented on the basis of vaccine technology. SO on the basis of vaccine technology the market is segmented as, live attenuated vaccines, inactive vaccines, toxoid vaccine, polysaccharide vaccines, conjugate vaccines, recombinant vaccines.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Prophylactic Human Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prophylactic Human Vaccines Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Prophylactic Human Vaccines Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prophylactic Human Vaccines Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Prophylactic Human Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prophylactic Human Vaccines Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Prophylactic Human Vaccines Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prophylactic Human Vaccines Market in these regions.
MARKET PLAYERS
The report covers key developments in the Prophylactic Human Vaccines Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Prophylactic Human Vaccines Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Prophylactic Human Vaccines market in the global market. Below mentioned is the list of few companies engaged in the Prophylactic Human Vaccines Market.
The report also includes the profiles of key players in Prophylactic Human Vaccines Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- GlaxoSmithKline Plc.
- Merck and Co., Inc.
- Pfizer, Inc.
- Janssen Pharmaceuticals, Inc.
- Altimmune, Inc.
- Bharat Biotech Limited
- Serum Institute of India, Pvt. Ltd
- Sanofi Pasteur SA
- Shanghai BravoBio Co., Ltd.
- SK Chemicals Co., Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prophylactic Human Vaccines Market - By Vaccine Technology
1.3.2 Prophylactic Human Vaccines Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROPHYLACTIC HUMAN VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. PROPHYLACTIC HUMAN VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROPHYLACTIC HUMAN VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. PROPHYLACTIC HUMAN VACCINES - GLOBAL MARKET OVERVIEW
6.2. PROPHYLACTIC HUMAN VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PROPHYLACTIC HUMAN VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE TECHNOLOGY
7.1. OVERVIEW
7.2. VACCINE TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. LIVE ATTENUATED VACCINES
7.3.1. Overview
7.3.2. Live Attenuated Vaccines Market Forecast and Analysis
7.4. INACTIVATED VACCINES
7.4.1. Overview
7.4.2. Inactivated Vaccines Market Forecast and Analysis
7.5. TOXOID VACCINES
7.5.1. Overview
7.5.2. Toxoid Vaccines Market Forecast and Analysis
7.6. POLYSACCHARIDE VACCINES
7.6.1. Overview
7.6.2. Polysaccharide Vaccines Market Forecast and Analysis
7.7. CONJUGATE VACCINES
7.7.1. Overview
7.7.2. Conjugate Vaccines Market Forecast and Analysis
7.8. RECOMBINANT VACCINES
7.8.1. Overview
7.8.2. Recombinant Vaccines Market Forecast and Analysis
8. PROPHYLACTIC HUMAN VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Prophylactic Human Vaccines Market Overview
8.1.2 North America Prophylactic Human Vaccines Market Forecasts and Analysis
8.1.3 North America Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.1.4 North America Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.1.4.1 United States Prophylactic Human Vaccines Market
8.1.4.1.1 United States Prophylactic Human Vaccines Market by Vaccine Technology
8.1.4.2 Canada Prophylactic Human Vaccines Market
8.1.4.2.1 Canada Prophylactic Human Vaccines Market by Vaccine Technology
8.1.4.3 Mexico Prophylactic Human Vaccines Market
8.1.4.3.1 Mexico Prophylactic Human Vaccines Market by Vaccine Technology
8.2. EUROPE
8.2.1 Europe Prophylactic Human Vaccines Market Overview
8.2.2 Europe Prophylactic Human Vaccines Market Forecasts and Analysis
8.2.3 Europe Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.2.4 Europe Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Prophylactic Human Vaccines Market
8.2.4.1.1 Germany Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.2 France Prophylactic Human Vaccines Market
8.2.4.2.1 France Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.3 Italy Prophylactic Human Vaccines Market
8.2.4.3.1 Italy Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.4 Spain Prophylactic Human Vaccines Market
8.2.4.4.1 Spain Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.5 United Kingdom Prophylactic Human Vaccines Market
8.2.4.5.1 United Kingdom Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.6 Rest of Europe Prophylactic Human Vaccines Market
8.2.4.6.1 Rest of Europe Prophylactic Human Vaccines Market by Vaccine Technology
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Prophylactic Human Vaccines Market Overview
8.3.2 Asia-Pacific Prophylactic Human Vaccines Market Forecasts and Analysis
8.3.3 Asia-Pacific Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.3.4 Asia-Pacific Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Prophylactic Human Vaccines Market
8.3.4.1.1 Australia Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.2 China Prophylactic Human Vaccines Market
8.3.4.2.1 China Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.3 India Prophylactic Human Vaccines Market
8.3.4.3.1 India Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.4 Japan Prophylactic Human Vaccines Market
8.3.4.4.1 Japan Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.5 South Korea Prophylactic Human Vaccines Market
8.3.4.5.1 South Korea Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.6 Rest of Asia-Pacific Prophylactic Human Vaccines Market
8.3.4.6.1 Rest of Asia-Pacific Prophylactic Human Vaccines Market by Vaccine Technology
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Prophylactic Human Vaccines Market Overview
8.4.2 Middle East and Africa Prophylactic Human Vaccines Market Forecasts and Analysis
8.4.3 Middle East and Africa Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.4.4 Middle East and Africa Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Prophylactic Human Vaccines Market
8.4.4.1.1 South Africa Prophylactic Human Vaccines Market by Vaccine Technology
8.4.4.2 Saudi Arabia Prophylactic Human Vaccines Market
8.4.4.2.1 Saudi Arabia Prophylactic Human Vaccines Market by Vaccine Technology
8.4.4.3 U.A.E Prophylactic Human Vaccines Market
8.4.4.3.1 U.A.E Prophylactic Human Vaccines Market by Vaccine Technology
8.4.4.4 Rest of Middle East and Africa Prophylactic Human Vaccines Market
8.4.4.4.1 Rest of Middle East and Africa Prophylactic Human Vaccines Market by Vaccine Technology
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Prophylactic Human Vaccines Market Overview
8.5.2 South and Central America Prophylactic Human Vaccines Market Forecasts and Analysis
8.5.3 South and Central America Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.5.4 South and Central America Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Prophylactic Human Vaccines Market
8.5.4.1.1 Brazil Prophylactic Human Vaccines Market by Vaccine Technology
8.5.4.2 Argentina Prophylactic Human Vaccines Market
8.5.4.2.1 Argentina Prophylactic Human Vaccines Market by Vaccine Technology
8.5.4.3 Rest of South and Central America Prophylactic Human Vaccines Market
8.5.4.3.1 Rest of South and Central America Prophylactic Human Vaccines Market by Vaccine Technology
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. PROPHYLACTIC HUMAN VACCINES MARKET, KEY COMPANY PROFILES
10.1. GLAXOSMITHKLINE PLC
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. MERCK AND CO., INC
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. PFIZER, INC
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. JANSSEN PHARMACEUTICALS, INC
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. ALTIMMUNE, INC
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. BHARAT BIOTECH INTERNATIONAL LIMITED
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. SERUM INSTITUTE OF INDIA PVT LTD
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. SANOFI PASTEUR SA
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SHANGHAI BRAVOBIO CO., LTD
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. SK CHEMICALS CO., LTD
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
1. GlaxoSmithKline Plc
2. Merck and Co., Inc
3. Pfizer, Inc
4. Janssen Pharmaceuticals, Inc
5. Altimmune, Inc
6. Bharat Biotech International Limited
7. Serum Institute of India Pvt Ltd
8. Sanofi Pasteur SA
9. Shanghai BravoBio Co., Ltd
10. SK Chemicals Co., Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For